A minor apolipoprotein that associates with HIGH-DENSITY LIPOPROTEINS (HDL), VERY-LOW-DENSITY LIPOPROTEINS (VLDL), and CHYLOMICRONS. It regulates levels of plasma TRIGLYCERIDES by activating APOLIPOPROTEIN C-II LIPOPROTEIN LIPASE and inhibiting hepatic VLDL triglyceride hydrolysis.
Apolipoprotein A V has been studied across 12 research domains including 🔥 Metabolic, ❤️ Cardiovascular, 🫁 Liver & Detox, 🧬 Hormones, 🔬 Oncology. The primary research focus is 🔥 Metabolic with 47% of studies addressing this area.
This evidence profile for Apolipoprotein A V is generated deterministically from 154 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.